ImmunoglobuliN in the Treatment of Encephalitis (IgNiTE): protocol for a multicentre randomised controlled trial

INTRODUCTION: Infectious and immune-mediated encephalitides are important but under-recognised causes of morbidity and mortality in childhood, with a 7% death rate and up to 50% morbidity after prolonged follow-up. There is a theoretical basis for ameliorating the immune response with intravenous im...

Descripción completa

Detalles Bibliográficos
Autores principales: Iro, M A, Sadarangani, M, Absoud, M, Chong, W K, Clark, C A, Easton, A, Gray, V, Kneen, R, Lim, M, Pike, M, Solomon, T, Vincent, A, Willis, L, Yu, L-M, Pollard, A J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Paediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129051/
https://www.ncbi.nlm.nih.gov/pubmed/27810972
http://dx.doi.org/10.1136/bmjopen-2016-012356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129051/
https://www.ncbi.nlm.nih.gov/pubmed/27810972
http://dx.doi.org/10.1136/bmjopen-2016-012356

Ejemplares similares